You are here

FDA approval

Cop 1 (Copaxone®): The Story of a Drug
01.05.1997

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

New Drug for Multiple Sclerosis Approved by the U.S. Food and Drug Administration
23.12.1996
REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli...
New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee
19.09.1996
REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...